BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12647710)

  • 1. Hypersensitivity to Mirena--a rare complication.
    Pereira A; Coker A
    J Obstet Gynaecol; 2003 Jan; 23(1):81. PubMed ID: 12647710
    [No Abstract]   [Full Text] [Related]  

  • 2. [A case report. Sepsis in connection with levonorgestrel IUD].
    Ottander U; Bäckström T; Högberg U; Löfgren M
    Lakartidningen; 1995 Nov; 92(48):4555-7. PubMed ID: 7490972
    [No Abstract]   [Full Text] [Related]  

  • 3. Levonorgestrel intrauterine device: new preparation. An alternative.
    Prescrire Int; 1999 Dec; 8(44):175-7. PubMed ID: 11503815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial polyp and the levonorgestrel intrauterine system--a case report and literature review.
    Sinha A; Nwosu EC
    J Obstet Gynaecol; 2002 Nov; 22(6):695. PubMed ID: 12554277
    [No Abstract]   [Full Text] [Related]  

  • 5. Levonorgestrel-releasing intrauterine system causes a lichenoid drug eruption.
    Jones JA; Shuler MJ; Zlotoff BJ
    Cutis; 2015 Jul; 96(1):E13-5. PubMed ID: 26244359
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe seborrhoeic dermatitis: side-effect of the Mirena intra-uterine system.
    Karri K; Mowbray D; Adams S; Rendal JR
    Eur J Contracept Reprod Health Care; 2006 Mar; 11(1):53-4. PubMed ID: 16546818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial granulomas with Levonorgestrel Intrauterine System (Mirena).
    Charlton F; Otton G; Hedges A; Scurry J
    Pathology; 2014 Aug; 46(5):457-8. PubMed ID: 24978028
    [No Abstract]   [Full Text] [Related]  

  • 8. Uterine perforation and laparoscopic retrieval of a levonorgestrel intrauterine system (Mirena).
    Selo-Ojeme DO; Ekong ME; Welch CC
    J Obstet Gynaecol; 2003 Jul; 23(4):445-6. PubMed ID: 12881099
    [No Abstract]   [Full Text] [Related]  

  • 9. Pseudo-decidual reaction to Mirena coil in a cervical smear: a potential diagnostic pitfall for false-positive cervical cytology.
    Hughes C; Woods J; Turner L; Gibbons D
    Cytopathology; 2005 Oct; 16(5):268-9. PubMed ID: 16181320
    [No Abstract]   [Full Text] [Related]  

  • 10. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
    Wildemeersch D; Janssens D; Andrade A
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intrauterine system (Mirena) and ectopic pregnancy--case report].
    Dvořák J; Toman A
    Ceska Gynekol; 2012 Oct; 77(5):414-5. PubMed ID: 23116345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the levonorgestrel-releasing intrauterine system and breast cancer.
    Tjalma WA; Trinh XB; van Dam PA
    Obstet Gynecol; 2006 Jan; 107(1):207-8; author reply 208. PubMed ID: 16394064
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma concentrations of levonorgestrel in patients with an intrauterine progestogen delivery system: do they have any significance?
    Trinh XB; van Dam PA; Tjalma WA
    Maturitas; 2006 Aug; 55(1):94-5; author reply 96-7. PubMed ID: 16675171
    [No Abstract]   [Full Text] [Related]  

  • 14. [Auto-immune progesterone-induced dermatitis].
    Freychet F; Ortonne JP
    Ann Dermatol Venereol; 1991; 118(8):551-5. PubMed ID: 1835332
    [No Abstract]   [Full Text] [Related]  

  • 15. Levonorgestrel-releasing intrauterine device and uterine perforations.
    Prescrire Int; 2007 Dec; 16(92):248-9. PubMed ID: 18092420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. I want my Mirena out!
    Puzey M
    S Afr Med J; 2004 Aug; 94(8):636. PubMed ID: 15352585
    [No Abstract]   [Full Text] [Related]  

  • 17. Insertion of intrauterine devices: a comparison of experience with Mirena and Multiload Cu 375 during post-marketing monitoring in New Zealand.
    Harrison-Woolrych M; Zhou L; Coulter D
    N Z Med J; 2003 Aug; 116(1179):U538. PubMed ID: 14513085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expulsion rate among users of two models of intrauterine devices (IUD), the Multiload 375 and the levonorgestrel-releasing intrauterine system (LNG-IUS, Mirena).
    Petta CA; Faundes D; Bahamondes L
    Eur J Obstet Gynecol Reprod Biol; 2009 Mar; 143(1):64; author reply 64-5. PubMed ID: 19150168
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
    Shaamash AH; Sayed GH; Hussien MM; Shaaban MM
    Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mirena (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception.
    Rose S; Chaudhari A; Peterson CM
    Adv Drug Deliv Rev; 2009 Aug; 61(10):808-12. PubMed ID: 19445984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.